Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Eva Ösby"'
Autor:
Håkan Mellstedt, Gunnar Juliusson, Eva Ösby, Bengt Simonsson, Bengt Smedmyr, C. Paul, B. Wadman, Bertil Johansson, Erik Svedmyr, H. Strander, Magnus Björkholm, M. Björeman, H. Gyllenhammar, Andreas Killander, Karl Merk, G. Brenning, G. Grimfors, G. Gahrton, A.-M. Stalfelt, Eva Kimby, Richard A. Lerner, M. Järnmark, A.-M. Udén, Anders Österborg, R. Hast
Publikováno v:
European Journal of Haematology. 43:124-128
A randomized study comparing melphalan/prednisone (M/P) therapy with MP + natural alpha-IFN in untreated patients with multiple myeloma stages II and III started April 1, 1986. By March 1989, 78 patients were evaluable in the MP group and 80 in the M
Publikováno v:
European Journal of Internal Medicine. 13:448-454
Background: Treatment with granulocyte colony-stimulating factor (G-CSF) is given in order to mitigate chemotherapy-induced granulocytopenia and the risk of infectious complications, which constitute a major threat to elderly patients, in particular,
Autor:
Magnus Björkholm, Inger Nennesmo, Eva Ösby, Anna Porwit, Anne Sundblad, Masih Ostad, Göran Holm, Kristian Borg
Publikováno v:
European Journal of Haematology. 67:189-193
Rhabdomyolysis is a rare complication in haematological malignancies, and a diverse range of factors has been implicated in the etiology of the syndrome. In the present study we analysed muscle morphology and antibody reactivities to skeletal muscle
Publikováno v:
Medical Oncology. 18:137-140
Estimation of complete response (CR) and partial response (PR) in patients with non-Hodgkin's lymphoma (NHL) is associated with a number of potential sources of error. The aim of this study was to define the reproducibility of response evaluation per
Publikováno v:
Medical Oncology. 18:269-276
Tumor responses after daily oral administration of low-dose etoposide have been demonstrated in both hematological and solid tumors. The aim of the present phase II trial was to determine tumor response, and toxicity and to delineate the pharmacokine
Autor:
Eva Ösby, Ann-Kari Lefvert, Magnus Björkholm, Göran Holm, R. Östman, Qing Yi, Anders Österborg, S. Bergenbrant
Publikováno v:
Scandinavian Journal of Immunology. 40:216-220
The prevalence of peripheral blood B cells secreting antibodies reacting with the F(ab')2 fragment of monoclonal IgG was studied in five patients with multiple myeloma (MM), nine patients with monoclonal gammopathy of undetermined significance (MGUS)
Autor:
Anders Österborg, Göran Holm, Ann-Kari Lefvert, Qing Yi, Magnus Björkholm, R. Östman, S. Bergenbrant, Eva Ösby
Publikováno v:
Scandinavian Journal of Immunology. 38:529-534
The stimulation of peripheral blood mononuclear cells by purified autologous and/or allogeneic monoclonal IgG was studied in five patients with multiple myeloma (MM), nine patients with monoclonal gammopathy of undetermined significance (MGUS) and si
Autor:
Magnus, Björkholm, Björkholm, Magnus, Tomas, Andersson, Andersson, Tomas, Anders, Ahlbom, Ahlbom, Anders, Eva, Ösby, Osby, Eva
Publikováno v:
European journal of haematology. 80(6)
Mitoxantrone has a broad anti-tumour activity including lymphoma with potentially less cardiotoxicity than doxorubicin, which may be of particular importance in elderly patients. However, an important issue is whether mitoxantrone is as efficacious a
Publikováno v:
Acta oncologica (Stockholm, Sweden). 43(3)
In general, elderly patients with aggressive non-Hodgkin's lymphoma (NHL) have a less favourable prognosis than younger patients. Established predictors of prognosis in NHL are less discriminatory in the elderly, which is why there is a need for addi
Autor:
H Hagberg, John Myhre, Lasse Teerenhovi, Hannu Pertovaara, Magnus Björkholm, Eva Cavallin-Ståhl, Harald Holte, Harald Anderson, Stein Kvaløy, Eva Ösby
Publikováno v:
Blood. 101(10)
This study was designed to test the hypothesis that administration of granulocyte colony-stimulating factor (G-CSF; filgrastim) during induction chemotherapy with CHOP (cyclophosphamide, vincristine, doxorubicin, prednisone) or CNOP (doxorubicin repl